Kosuke Ogawa

1.6k total citations
59 papers, 970 citations indexed

About

Kosuke Ogawa is a scholar working on Oncology, Surgery and Epidemiology. According to data from OpenAlex, Kosuke Ogawa has authored 59 papers receiving a total of 970 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 18 papers in Surgery and 18 papers in Epidemiology. Recurrent topics in Kosuke Ogawa's work include Pancreatic and Hepatic Oncology Research (17 papers), Neuroendocrine Tumor Research Advances (11 papers) and Lung Cancer Research Studies (10 papers). Kosuke Ogawa is often cited by papers focused on Pancreatic and Hepatic Oncology Research (17 papers), Neuroendocrine Tumor Research Advances (11 papers) and Lung Cancer Research Studies (10 papers). Kosuke Ogawa collaborates with scholars based in Japan, United States and China. Kosuke Ogawa's co-authors include Minoru Tanabe, Atsushi Kudo, Hiroaki Ono, Daisuke Ban, Shinji Tanaka, Yusuke Mitsunori, Toshiro Ogura, Yoshimitsu Akiyama, Shu Shimada and Shuichi Watanabe and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Annals of Surgery.

In The Last Decade

Kosuke Ogawa

56 papers receiving 958 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kosuke Ogawa Japan 16 376 299 210 167 165 59 970
Yasuyuki Aoyagi Japan 16 295 0.8× 395 1.3× 186 0.9× 136 0.8× 348 2.1× 24 1.3k
Carola Heneweer Germany 18 276 0.7× 257 0.9× 80 0.4× 101 0.6× 257 1.6× 35 1.1k
L. Tietze Germany 18 353 0.9× 227 0.8× 151 0.7× 187 1.1× 87 0.5× 39 1.2k
Kunihiro Masuda Japan 18 343 0.9× 366 1.2× 112 0.5× 148 0.9× 64 0.4× 56 1.3k
Jingjing Li China 20 421 1.1× 891 3.0× 97 0.5× 143 0.9× 209 1.3× 96 1.4k
Li‐Chun Lu Taiwan 22 262 0.7× 419 1.4× 170 0.8× 204 1.2× 107 0.6× 60 1.2k
Joachim Høg Mortensen Denmark 17 262 0.7× 148 0.5× 110 0.5× 123 0.7× 47 0.3× 62 1.1k
Reynold I. Lopez‐Soler United States 17 427 1.1× 174 0.6× 75 0.4× 91 0.5× 74 0.4× 41 1.0k
Annemie Collen Netherlands 9 284 0.8× 135 0.5× 182 0.9× 131 0.8× 90 0.5× 10 863
Albrecht Leo Germany 19 478 1.3× 238 0.8× 71 0.3× 87 0.5× 144 0.9× 40 1.5k

Countries citing papers authored by Kosuke Ogawa

Since Specialization
Citations

This map shows the geographic impact of Kosuke Ogawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kosuke Ogawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kosuke Ogawa more than expected).

Fields of papers citing papers by Kosuke Ogawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kosuke Ogawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kosuke Ogawa. The network helps show where Kosuke Ogawa may publish in the future.

Co-authorship network of co-authors of Kosuke Ogawa

This figure shows the co-authorship network connecting the top 25 collaborators of Kosuke Ogawa. A scholar is included among the top collaborators of Kosuke Ogawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kosuke Ogawa. Kosuke Ogawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ono, Hiroaki, Yoshiya Ishikawa, Shuichi Watanabe, et al.. (2023). RRM1 is mediated by histone acetylation through gemcitabine resistance and contributes to invasiveness and ECM remodeling in pancreatic cancer. International Journal of Oncology. 62(4). 11 indexed citations
2.
Sugawara, Toshitaka, Daisuke Ban, Jo Nishino, et al.. (2021). Prediction of early recurrence of pancreatic ductal adenocarcinoma after resection. PLoS ONE. 16(4). e0249885–e0249885. 14 indexed citations
3.
Ono, Hiroaki, Yutaro Nakamura, Yoshiya Ishikawa, et al.. (2021). C646 inhibits G2/M cell cycle-related proteins and potentiates anti-tumor effects in pancreatic cancer. Scientific Reports. 11(1). 10078–10078. 28 indexed citations
4.
Ono, Hiroaki, Keiichi Akahoshi, Toshiro Ogura, et al.. (2021). Cytoplasmic RRM1 activation as an acute response to gemcitabine treatment is involved in drug resistance of pancreatic cancer cells. PLoS ONE. 16(6). e0252917–e0252917. 13 indexed citations
5.
Matsui, Satoshi�, Toshiro Ogura, Daisuke Ban, et al.. (2019). Position of the Pancreas Division Line and Postoperative Outcomes After Distal Pancreatectomy. World Journal of Surgery. 44(4). 1244–1251. 3 indexed citations
6.
Nagaoka, Katsuya, Xuewei Bai, Kosuke Ogawa, et al.. (2019). Anti-tumor activity of antibody drug conjugate targeting aspartate-β-hydroxylase in pancreatic ductal adenocarcinoma. Cancer Letters. 449. 87–98. 19 indexed citations
7.
Lin, Qiushi, Xuesong Chen, Fanzheng Meng, et al.. (2019). ASPH-notch Axis guided Exosomal delivery of Prometastatic Secretome renders breast Cancer multi-organ metastasis. Molecular Cancer. 18(1). 156–156. 66 indexed citations
8.
Ogawa, Kosuke, et al.. (2019). Primary small cell neuroendocrine carcinoma of adrenal gland. International Cancer Conference Journal. 8(3). 122–125. 9 indexed citations
9.
Mizuno, Yuki, Shu Shimada, Yoshimitsu Akiyama, et al.. (2018). DEPDC5 deficiency contributes to resistance to leucine starvation via p62 accumulation in hepatocellular carcinoma. Scientific Reports. 8(1). 106–106. 18 indexed citations
10.
Mizuno, Yuki, Atsushi Kudo, Takumi Akashi, et al.. (2018). Sunitinib shrinks NET-G3 pancreatic neuroendocrine neoplasms. Journal of Cancer Research and Clinical Oncology. 144(6). 1155–1163. 38 indexed citations
11.
Shimada, Shu, Kaoru Mogushi, Yoshimitsu Akiyama, et al.. (2018). Comprehensive molecular and immunological characterization of hepatocellular carcinoma. EBioMedicine. 40. 457–470. 179 indexed citations
12.
Ogawa, Kosuke, et al.. (2018). A case of rapidly progressing prostate cancer diagnosed 20 months after holmium laser enucleation of the prostate. International Cancer Conference Journal. 7(3). 81–83. 2 indexed citations
13.
Shimada, Shu, Yoshimitsu Akiyama, Kaoru Mogushi, et al.. (2018). Fatty Acid Binding Protein 4 (FABP4) Overexpression in Intratumoral Hepatic Stellate Cells within Hepatocellular Carcinoma with Metabolic Risk Factors. American Journal Of Pathology. 188(5). 1213–1224. 54 indexed citations
14.
Watanabe, Shuichi, Shu Shimada, Yoshimitsu Akiyama, et al.. (2018). Loss of KDM6A characterizes a poor prognostic subtype of human pancreatic cancer and potentiates HDAC inhibitor lethality. International Journal of Cancer. 145(1). 192–205. 48 indexed citations
15.
Iwagami, Yoshifumi, Sarah Casulli, Katsuya Nagaoka, et al.. (2017). Lambda phage-based vaccine induces antitumor immunity in hepatocellular carcinoma. Heliyon. 3(9). e00407–e00407. 36 indexed citations
16.
Miyaji, Hirofumi, Hiroko Takita, Toshihiko Iwanaga, et al.. (2016). Graphene oxide scaffold accelerates cellular proliferative response and alveolar bone healing of tooth extraction socket. International Journal of Nanomedicine. 11. 2265–2265. 86 indexed citations
17.
Miyaji, Hirofumi, Hiroyuki Nishimura, Saori Tanaka, et al.. (2013). Bone augmentation in rat by highly porous β-TCP scaffolds with different open-cell sizes in combination with fibroblast growth factor-2. Hokkaido University Collection of Scholarly and Academic Papers (Hokkaido University). 2 indexed citations
18.
Tomita, Naoto, Fumio Kodama, S Motomura, et al.. (2007). Adjuvant radiotherapy to an initial bulky mass in diffuse large B‐cell lymphoma: lack of survival benefit. International Journal of Laboratory Hematology. 30(1). 53–57. 6 indexed citations
19.
Sekiguchi, Yuichiro, et al.. (2000). [Rebound of prostate specific antigen after discontinuation of antiandrogen therapy for benign prostatic hyperplasia].. PubMed. 46(9). 605–7. 2 indexed citations
20.
Ogawa, Kosuke, et al.. (1994). Induction chemotherapy (cisplatin and 5-fluorouracil) and irradiation for nasopharyngeal cancer. 29(9). 1629–1638. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026